CN112062402A - Biomembrane reaction type pharmaceutical wastewater treatment method - Google Patents

Biomembrane reaction type pharmaceutical wastewater treatment method Download PDF

Info

Publication number
CN112062402A
CN112062402A CN202010935053.8A CN202010935053A CN112062402A CN 112062402 A CN112062402 A CN 112062402A CN 202010935053 A CN202010935053 A CN 202010935053A CN 112062402 A CN112062402 A CN 112062402A
Authority
CN
China
Prior art keywords
wastewater
coagulating sedimentation
sedimentation tank
treatment
sequencing batch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010935053.8A
Other languages
Chinese (zh)
Inventor
顾延翔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Zhongzhi Xinyu Environmental Technology Co ltd
Original Assignee
Jiangsu Zhongzhi Xinyu Environmental Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Zhongzhi Xinyu Environmental Technology Co ltd filed Critical Jiangsu Zhongzhi Xinyu Environmental Technology Co ltd
Priority to CN202010935053.8A priority Critical patent/CN112062402A/en
Publication of CN112062402A publication Critical patent/CN112062402A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F9/00Multistage treatment of water, waste water or sewage
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/001Processes for the treatment of water whereby the filtration technique is of importance
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/34Treatment of water, waste water, or sewage with mechanical oscillations
    • C02F1/36Treatment of water, waste water, or sewage with mechanical oscillations ultrasonic vibrations
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/52Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities
    • C02F1/54Treatment of water, waste water, or sewage by flocculation or precipitation of suspended impurities using organic material
    • C02F1/56Macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/34Nature of the water, waste water, sewage or sludge to be treated from industrial activities not provided for in groups C02F2103/12 - C02F2103/32
    • C02F2103/343Nature of the water, waste water, sewage or sludge to be treated from industrial activities not provided for in groups C02F2103/12 - C02F2103/32 from the pharmaceutical industry, e.g. containing antibiotics
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00Specific treatment goals
    • C02F2303/04Disinfection
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00Biological treatment of water, waste water, or sewage
    • C02F3/30Aerobic and anaerobic processes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)

Abstract

The invention relates to the technical field of wastewater treatment, in particular to a biomembrane reaction type pharmaceutical wastewater treatment method. The method comprises the following steps: a) the pharmaceutical wastewater enters an adjusting tank for stirring and pre-aeration treatment, and the treated wastewater is sent into a coagulating sedimentation tank; b) a flocculating agent is added into the coagulating sedimentation tank, after suspended matters in the wastewater are removed by the coagulating sedimentation tank, the wastewater enters the sequencing batch biofilm reactor, and sludge discharged from the coagulating sedimentation tank is transported outside for treatment; c) after microorganisms in the wastewater are removed by the sequencing batch biofilm reactor, the wastewater is sent into a filter tank for ultrasonic disinfection, and water which reaches the discharge standard is obtained after disinfection. The invention carries out anaerobic, anoxic and aerobic processes by using the sequencing batch biofilm reactor to treat aerobic, attached facultative and attached anaerobic microorganisms. Through ultrasonic disinfection, avoid throwing into medicine to the aquatic to can not influence quality of water. This application has improved the waste water treatment effect, has practiced thrift the cost.

Description

Biomembrane reaction type pharmaceutical wastewater treatment method
Technical Field
The invention relates to the technical field of wastewater treatment, in particular to a biomembrane reaction type pharmaceutical wastewater treatment method.
Background
The pharmaceutical industry wastewater mainly comprises four types of antibiotic production wastewater, synthetic drug production wastewater, Chinese patent drug production wastewater, and washing water and flushing wastewater in the production process of various preparations. The waste water has the characteristics of complex components, high organic matter content, high toxicity, deep chromaticity, high salt content, particularly poor biodegradability, and intermittent discharge, and belongs to industrial waste water which is difficult to treat. With the development of the pharmaceutical industry in China, pharmaceutical wastewater gradually becomes one of important pollution sources, and how to treat the wastewater is a difficult problem of environmental protection at present. The prior art usually ignores the unique characteristics of pharmaceutical wastewater, and generally adopts a general process flow of pretreatment and biochemical treatment reinforcement liquid separation. The process occupies a large area and consumes much energy.
Disclosure of Invention
In order to solve the technical problems described in the background art, the invention provides a biomembrane reaction type pharmaceutical wastewater treatment method, which carries out anaerobic, anoxic and aerobic processes through a sequencing batch biomembrane reactor to treat aerobic, attached facultative and attached anaerobic microorganisms. Through ultrasonic disinfection, avoid throwing into medicine to the aquatic to can not influence quality of water. This application has improved the waste water treatment effect, has practiced thrift the cost.
The technical scheme adopted by the invention for solving the technical problems is as follows:
a biomembrane reaction type pharmaceutical wastewater treatment method comprises the following steps:
a) the pharmaceutical wastewater enters an adjusting tank for stirring and pre-aeration treatment, and the treated wastewater is sent into a coagulating sedimentation tank;
b) a flocculating agent is added into the coagulating sedimentation tank, after suspended matters in the wastewater are removed by the coagulating sedimentation tank, the wastewater enters the sequencing batch biofilm reactor, and sludge discharged from the coagulating sedimentation tank is transported outside for treatment;
c) after microorganisms in the wastewater are removed by the sequencing batch biofilm reactor, the wastewater is sent into a filter tank for ultrasonic disinfection, and water which reaches the discharge standard is obtained after disinfection.
Specifically, the flocculant is polyacrylamide.
The invention has the beneficial effects that: the invention provides a biomembrane reaction type pharmaceutical wastewater treatment method, which carries out anaerobic, anoxic and aerobic processes through a sequencing batch biomembrane reactor to treat aerobic, attached facultative and attached anaerobic microorganisms. Through ultrasonic disinfection, avoid throwing into medicine to the aquatic to can not influence quality of water. This application has improved the waste water treatment effect, has practiced thrift the cost.
Drawings
The invention is further described with reference to the following figures and examples.
FIG. 1 is a schematic diagram of the framework of the present invention;
Detailed Description
The invention will now be described in further detail with reference to the accompanying drawings. These drawings are simplified schematic diagrams illustrating only the basic structure of the invention in a schematic manner, and thus show only the constitution related to the invention.
Fig. 1 is a schematic diagram of the framework of the present invention.
As shown in the attached figure 1, a biomembrane reaction type pharmaceutical wastewater treatment method comprises the following steps:
a) the pharmaceutical wastewater enters an adjusting tank for stirring and pre-aeration treatment, and the treated wastewater is sent into a coagulating sedimentation tank;
b) a flocculating agent is added into the coagulating sedimentation tank, after suspended matters in the wastewater are removed by the coagulating sedimentation tank, the wastewater enters the sequencing batch biofilm reactor, and sludge discharged from the coagulating sedimentation tank is transported outside for treatment;
c) after microorganisms in the wastewater are removed by the sequencing batch biofilm reactor, the wastewater is sent into a filter tank for ultrasonic disinfection, and water which reaches the discharge standard is obtained after disinfection.
The flocculating agent is polyacrylamide.
The coagulating sedimentation tank is one of sedimentation tanks in water supply and drainage. The coagulation process is the most basic and very important treatment process in the treatment of industrial water and domestic sewage, and by adding some medicaments (generally called coagulant and coagulant aid) into water, particles which are difficult to precipitate in the water can be polymerized with each other to form colloid, and then are combined with impurities in the water body to form larger floccules. The flocculating constituent has strong adsorption capacity, can adsorb suspended matters, and can adsorb partial bacteria and soluble substances. The flocs sink down by increasing their volume through adsorption.
A Sequencing Batch Biofilm Reactor (Sequencing Biofilm Batch Reactor), also known as a membrane SBR (BABR), is a new biological sewage treatment process which is researched and applied at home and abroad. The sequencing batch biofilm reactor is a novel composite biofilm reactor developed by filling different fillers (such as fiber fillers, activated carbon, ceramsite and the like) in an SBR reactor, and the intervention of the fillers provides a more favorable living environment for microorganisms. The microorganisms form a complex ecosystem consisting of a plurality of nutrition levels such as bacteria, fungi, algae, protozoa, metazoan and the like in the longitudinal direction, and form a suspended aerobic type, attached facultative type and attached anaerobic type microorganism system with various different activities, breathing types and nutrition types in the transverse direction along the direction of water flowing to the carrier, thereby greatly improving the processing capacity and stability of the reactor, and the advantages of stable reaction process, more and complex biomass, less residual sludge, less power consumption and small occupied area of the sequencing batch biofilm reactor are achieved.
The sterilization and disinfection mechanism of the ultrasonic wave is that the ultrasonic wave can perform ultrasonic cavitation in liquid to instantly generate hundreds of millions of cavitation micro bubbles, a plurality of cavitation bubbles are instantly generated and instantly exploded, meanwhile, the temperature of the liquid is continuously increased along with high temperature and high pressure, a hand is stretched into the liquid to feel pinprick, the cavitation generates strong mechanical shearing action, and the cell walls of microorganisms can be broken, so that the cell contents overflow out of the cell walls, and thus, certain components in the cells, such as DNA, RNA, amino acid, alkaloid, protein and the like can be extracted. The adoption of ultrasonic wave sterilization avoids the generation of harmful byproducts and the irreversible influence on human bodies and the environment. In addition, the characteristic of large water volume of the papermaking wastewater is that the cost of the medicament is obviously increased if chlorine adding disinfection is continuously adopted, and the ultrasonic disinfection mode does not need to add any substance into water, so that the cost is superior to that of the chlorine adding disinfection firstly, and other substances do not need to be added, so that the water quality is not affected by adopting the ultrasonic disinfection.
In light of the foregoing description of preferred embodiments according to the invention, many modifications and variations can be made by the worker skilled in the art without departing from the scope of the invention. The technical scope of the present invention is not limited to the content of the specification, and must be determined according to the scope of the claims.

Claims (2)

1. A biomembrane reaction type pharmaceutical wastewater treatment method is characterized in that: the method comprises the following steps:
a) the pharmaceutical wastewater enters an adjusting tank for stirring and pre-aeration treatment, and the treated wastewater is sent into a coagulating sedimentation tank;
b) a flocculating agent is added into the coagulating sedimentation tank, after suspended matters in the wastewater are removed by the coagulating sedimentation tank, the wastewater enters the sequencing batch biofilm reactor, and sludge discharged from the coagulating sedimentation tank is transported outside for treatment;
c) after microorganisms in the wastewater are removed by the sequencing batch biofilm reactor, the wastewater is sent into a filter tank for ultrasonic disinfection, and water which reaches the discharge standard is obtained after disinfection.
2. The method of claim 1, wherein the step of treating the wastewater comprises: the flocculant is polyacrylamide.
CN202010935053.8A 2020-09-08 2020-09-08 Biomembrane reaction type pharmaceutical wastewater treatment method Pending CN112062402A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010935053.8A CN112062402A (en) 2020-09-08 2020-09-08 Biomembrane reaction type pharmaceutical wastewater treatment method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010935053.8A CN112062402A (en) 2020-09-08 2020-09-08 Biomembrane reaction type pharmaceutical wastewater treatment method

Publications (1)

Publication Number Publication Date
CN112062402A true CN112062402A (en) 2020-12-11

Family

ID=73664328

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010935053.8A Pending CN112062402A (en) 2020-09-08 2020-09-08 Biomembrane reaction type pharmaceutical wastewater treatment method

Country Status (1)

Country Link
CN (1) CN112062402A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103739142A (en) * 2013-11-15 2014-04-23 安徽省绿巨人环境技术有限公司 Chinese patent medicine production wastewater treatment technology
CN110526526A (en) * 2019-09-25 2019-12-03 江苏众志新禹环境科技有限公司 The method of Pharmaceutical Wastewater Treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103739142A (en) * 2013-11-15 2014-04-23 安徽省绿巨人环境技术有限公司 Chinese patent medicine production wastewater treatment technology
CN110526526A (en) * 2019-09-25 2019-12-03 江苏众志新禹环境科技有限公司 The method of Pharmaceutical Wastewater Treatment

Similar Documents

Publication Publication Date Title
CN103011525B (en) Anaerobic biochemical sewage treatment system and method
CN102452770A (en) Biochemical treatment/advanced oxidation treatment coupled sewage treatment technique
CN102276108A (en) Livestock/poultry biogas slurry purification device and method
CN103508637B (en) Traditional Chinese medicine wastewater treatment system and method for treating traditional Chinese medicine wastewater
CN105776766A (en) Advanced treatment system for biorefractory wastewater of industrial park
CA2909559A1 (en) Enhanced biosorption of wastewater organics using dissolved air flotation with solids recycle
CN109534601A (en) A kind of biochemical method for combining electrocatalytic oxidation processing landfill leachate
CN103613254A (en) Method for deep treatment of refractory organic wastewater of sewage treatment plant in fine chemical industry park
CN100591632C (en) Advanced treatment method and device for dyeing waste water by ozone iron zinc catalysis
CN105130096A (en) Chemical engineering sewage deep treatment system
CN112624510A (en) Sewage advanced treatment combined device and process
CN113087314A (en) Wastewater treatment system and treatment process
Feng Research progress in pharmaceutical wastewater treatment technology
CN205152010U (en) Industry pharmacy effluent disposal system
CN106746223A (en) Aerobic collaboration processing cutting liquid waste plant and the method for coagulation anaerobic hydrolysis
CN103183451A (en) Method for treating printing and dyeing wastewater by composite biological enzyme
CN109534606A (en) A kind of fermented pharmaceutical waste water treatment process
CN206328290U (en) The aerobic collaboration processing cutting liquid waste plant of coagulation anaerobic hydrolysis
CN112062402A (en) Biomembrane reaction type pharmaceutical wastewater treatment method
CN104692592A (en) Dye wastewater advanced treatment and recycling device and process
CN212687845U (en) Pharmaceutical wastewater comprehensive treatment device
Al-Amshawee et al. A review on hybrid processes for palm oil mill effluent: possible approaches
CN203530057U (en) Wastewater pretreatment device in production of chemical synthesis raw material medicines
CN105776684A (en) Urban sewage treatment and resource recycling method
CN112408707A (en) Medical intermediate wastewater treatment process

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201211

RJ01 Rejection of invention patent application after publication